D

Dyne Therapeutics
D

DYN

29.700
USD
-0.09
(-0.30%)
Market Closed
Volume
26,664
EPS
-4
Div Yield
-
P/E
-8
Market Cap
3,022,448,953
OverviewSignalsIdeasNews
Related Instruments
    A
    AEE
    1.470
    (1.64%)
    91.190 USD
    DTE
    DTE
    0.670
    (0.56%)
    120.060 USD
    EIX
    EIX
    1.540
    (1.88%)
    83.670 USD
    EXC
    EXC
    0.990
    (2.60%)
    39.130 USD
    F
    FE
    0.670
    (1.64%)
    41.510 USD
    PCG
    PCG
    0.010
    (0.05%)
    21.000 USD
    P
    PPL
    0.495
    (1.49%)
    33.720 USD
    SO
    SO
    1.150
    (1.33%)
    87.920 USD
    W
    WEC
    1.850
    (1.92%)
    97.990 USD
    XEL
    XEL
    0.550
    (0.80%)
    69.470 USD
    More
News

Title: Dyne Therapeutics

Sector: Healthcare
Industry: Biotechnology
Dyne Therapeutics Inc is a biotechnology company focused on providing therapeutics for patients with genetically driven diseases. The company overcomes the limitations of muscle tissue delivery and modern oligonucleotide therapeutics for muscle diseases. The company is developing therapies for muscle disorders like Myotonic dystrophy, Duchenne muscular dystrophy, and Facioscapulohumeral muscular dystrophy. The company's product candidates are DYNE-101 and DYNE-251, both arein the ongoing phase 1/2 clinical trial.